Replies to post #49489 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Your first statement makes no sense, and no, I have not talked to Les lately.

You don't know we have not reached sufficient enrollment. If we have not reached sufficient enrollment, the 2011 guidelines for vaccine immunotherapy that contemplate trial maturity may give some indication why.